Abstract-In this study, we investigated whether the fast-twitch skeletal muscle sarco(endo)plasmic reticulum Ca 2ϩ transport pump (SERCA1a) can functionally substitute the cardiac SERCA2a isoform and how its overexpression affects cardiac contractility. For this purpose, we generated transgenic (TG) mice that specifically overexpress SERCA1a in the heart, using the cardiac-specific ␣-myosin heavy chain promoter. Ectopic expression of SERCA1a resulted in a 2.5-fold increase in the amount of total SERCA protein. At the same time, the level of the endogenous SERCA2a protein was decreased by 50%, whereas the level of other muscle proteins, including calsequestrin, phospholamban, actin, and tropomyosin, remained unchanged. The steady-state level of SERCA phosphoenzyme intermediate was increased 2.5-fold, and the maximal velocity of Ca 2ϩ uptake was increased 1.7-fold in TG hearts, demonstrating that the overexpressed protein is functional. Although the basal cytosolic calcium signal was decreased by 38% in TG cardiomyocytes, the amplitude of cytosolic calcium signal was increased by 71.8%. The rate of calcium resequestration was also increased in TG myocytes, which was reflected by a 51.6% decrease in the normalized time to 80% decay of calcium signal. This resulted in considerably increased peak rates of myocyte shortening and relengthening (50.0% and 66.6%, respectively). Cardiac functional analysis using isolated work-performing heart preparations revealed significantly faster rates of contraction and relaxation in TG hearts (41.9% and 39.5%, respectively). The time to peak pressure and the time to half-relaxation were shorter (29.1% and 32.7%, respectively). In conclusion, our study demonstrates that the SERCA1a pump can functionally substitute endogenous SERCA2a, and its overexpression significantly enhances Ca 2ϩ transport and contractile function of the myocardium. These results also demonstrate that the SERCA pump level is a critical determinant of cardiac contractility. (Circ Res. 1998;83:889-897.)
I n cardiac and skeletal muscle, contraction and relaxation are regulated by cyclic release and removal of Ca 2ϩ by the sarcoplasmic reticulum (SR). Release of Ca 2ϩ from the SR initiates muscle contraction, whereas reuptake of Ca 2ϩ into the SR results in muscle relaxation. 1 The rate of muscle relaxation is determined largely by the Ca 2ϩ uptake function of the SR Ca 2ϩ /Mg 2ϩ -ATPase (SERCA). 2 This enzyme is a transmembrane protein of ϳ110 kDa and belongs to a family of highly conserved proteins. Three different genes, SERCA1, SERCA2, and SERCA3, have been identified. 3 The SERCA1 gene encodes 2 isoforms, SERCA1a and SERCA1b, expressed in adult and neonatal fast-twitch skeletal muscle, respectively, but never in the heart. 4 The SERCA2 gene encodes 2 different isoforms, SERCA2a and SERCA2b. SERCA2a is the primary cardiac isoform 5 but also is expressed in slow-twitch skeletal muscle. The SERCA2b isoform is expressed in most smooth muscle and nonmuscle tissues, 6 whereas the SERCA3 isoform is expressed primarily in epithelial and endothelial cells. 7 The differential expression of SERCA1a and SERCA2a isoforms in skeletal and cardiac muscles suggests that they may have distinct Ca 2ϩ uptake properties. However, it is unclear whether the differential isoform expression is purely an evolutional coincidence or provides for unique muscle contractile characteristics.
Studies from our laboratory and others' have shown that the SR Ca 2ϩ -ATPase pump level is altered significantly during cardiac adaptation to pressure overload and changes in thyroid hormone level. 8 -15 Using tissue samples from failing human hearts, we and others have found that the expression level of SR Ca 2ϩ -ATPase was decreased both at the mRNA 16 -19 and the protein levels 20 in end-stage heart failure. Intracellular Ca 2ϩ measurements showed that Ca 2ϩ transients in muscle samples from failing human hearts were prolonged markedly in both Ca 2ϩ release and uptake phases. 21, 22 The decrease in the levels of SR Ca 2ϩ -ATPase can be correlated closely with a decreased myocardial function. 20, 23 Recently, adenovirus-mediated gene transfer of SERCA2a into failing cardiomyocytes has been shown to reconstitute depressed pump level and shorten prolonged Ca 2ϩ transients, paving the way for potential gene therapy to treat heart failure. 24 However, this approach should not be restricted to the use of cardiac isoform SERCA2a only. In a recent study, Inesi et al 25 used adenovirus-mediated gene transfer overexpressed SERCA1 isoform in chicken embryonic cardiac myocytes. They showed that SERCA1 overexpression resulted in a 4-fold increase in the rates of Ca 2ϩ transport activity. Cytosolic Ca 2ϩ transients and tension development of transfected myocytes also were enhanced by SERCA1 overexpression, suggesting that SERCA1 can be functional in cardiac myocytes. The goal of this study was to develop a transgenic (TG) mouse model to explore how SERCA1a overexpression affects cardiac contractility and Ca 2ϩ transport function in the intact heart. The use of a TG mouse model overcomes certain limitations of in vitro systems and provides us with an in vivo system to study the properties of different isoforms in cardiac environment and the various aspects of excitation-contraction coupling and Ca 2ϩ handling in response to SERCA pump overexpression.
To determine whether SERCA1a functionally can substitute SERCA2a in the heart, we created a TG mouse model in which SERCA1a protein is expressed in the heart using the cardiac ␣-myosin heavy chain (MHC) promoter. Ectopic expression of SERCA1a in the heart resulted in a 2.5-fold increase in the total SERCA protein but caused a 50% decrease in the level of endogenous SERCA2a protein. As a result, the Ca 2ϩ transport function in TG hearts was considerably increased, and TG hearts demonstrated significantly enhanced rates of contraction and relaxation, suggesting that the SERCA pump level is a critical determinant of myocardial contractility.
Materials and Methods

Generation of SERCA1a TG Mice
The complete coding and 3Ј-untranslated region of rat SERCA1a cDNA 26 was ligated into the SalI site of plasmid pCl26 downstream of 5.5 kb mouse cardiac ␣-MHC promoter. 27 SERCA1a cDNA 5Ј-untranslated sequence was removed, and the sequence preceding the first ATG codon was modified to provide for efficient mRNA translation. The resulting plasmid, pCl26-S1a, was confirmed by restriction mapping and nucleotide sequencing. A linear 9.6-kb DNA fragment containing the entire cardiac ␣-MHC promoter, the complete rat SERCA1a cDNA open reading frame, and 3Ј-untranslated region followed by human growth hormone (Hgh) polyadenylation signal was purified from plasmid sequences. The DNA was used for microinjection of fertilized mouse eggs and production of TG mice. 28 Polymerase chain reaction was used to screen 3-week-old pups for the presence of the transgene. Primers cardiac ␣-MHC (5Ј-GCCCACACCAGAAATGACAGA-3Ј) complementary to cardiac ␣-MHC promoter and PR3 (5Ј-TCGATGGCATTCTCTGCATTCC-3Ј) complementary to rat SERCA1a cDNA were used. Stable TG lines were raised by breeding the founder mice with nontransgenic (NTG) cohorts. All animal care and procedures were approved by the University of Cincinnati Institutional Animal Care and Use Committee and complied with the Guide for the Care and Use of Laboratory Animals (NIH publication No. 1985) .
Genomic Southern and Dot Blotting
Genomic DNA was isolated from tail clips and digested with BamHI to yield a unique 2-kb fragment, characteristic for the transgene. The DNA was electrophoresed in 0.8% agarose gel and transferred on nylon membranes. The copy number of the transgene in each line was determined by quantitative DNA dot blot analysis. 29 Samples of BamHI-digested DNA (10 g) were applied on nylon membranes, and a serial dilution of purified ␣-MHC/SERCA1a/Hgh fragment was used as a standard. The membranes were probed with 32 P-labeled 0.9-kb XhoI-NotI Hgh-fragment. Quantitation was carried out on PhosphorImager using ImageQuant V 3.0 analysis system (Molecular Dynamics).
Northern Blot Analysis
Total RNA extraction from whole TG and NTG mouse hearts, rat hearts, and rat fast-twitch skeletal muscle, size-fractionation in formaldehyde agarose gel (10 g/lane), transfer on nylon membranes, and hybridization were performed using standard protocols. 30 BglII restriction fragment (377 bp) corresponding to the 3Ј-end of rat SERCA1a cDNA was 32 P-labeled and used to characterize SERCA1a mRNA level in mouse hearts. The membranes were washed at high stringency (0.2ϫSSC/0.1% SDS; 65°C).
Protein and Western Blot Analysis
To determine the level of total SERCA protein in TG hearts, we used a combination of quantitative SDS-PAGE with Western blot analysis as follows. SR-enriched microsomes were prepared from the whole TG and NTG mouse hearts as previously described. 31 Equal amounts of TG and NTG microsomal proteins were separated in SDS-PAGE and stained with Coomassie blue according to standard protocols. 30 In TG microsomes only, the SERCA band (110 kDa) was enhanced, compared with NTG microsomes. The identity of SERCA band was confirmed by Western blot analysis. After SDS-PAGE, the proteins were transferred onto nitrocellulose filters and stained transiently with Ponceau S (Sigma). The position of the 110-kDa band was marked, and after washing out of the stain, the filters were probed with a SERCA2a-specific polyclonal antibody 32 or a monoclonal SERCA1a-specific antibody, A-52. 33 The SERCA2a antibody crossreacted with the 110-kDa band in both TG and NTG samples, whereas the SERCA1a antibody cross-reacted with the 110-kDa band only in TG samples, but not in NTG samples. This demonstrated that the 110-kDa band indeed corresponds to SERCA (SERCA2a in NTG microsomes and SERCA1aϩSERCA2a in TG microsomes).
To accurately determine the total amount of SERCA protein in TG hearts, a quantitative SDS-PAGE analysis was used. The increasing amounts of TG and NTG microsomal proteins (8, 12, 16 , and 20 g/lane) were separated in the same gels and stained with Coomassie blue. The gels were scanned with UMAX Astra 1200S scanner using Vista Scan DA V 1.2.2 program, and the data were analyzed using NIH Image 1.61 software. To obtain the standard protein curves, the SERCA band signal was plotted against the concentration of microsomal proteins. Three different preparations of TG and NTG microsomes were used, and at least 3 separate gels were run per preparation. The total amount of SERCA protein in TG hearts was determined using standard protein curves.
Quantitative immunoblotting with SERCA1a-specific antibody, A-52, 33 SERCA2a-specific polyclonal antibody, 32 monoclonal antiphospholamban antibody (Affinity Bioreagents, Inc), a monoclonal anti-␣-sarcomeric actin antibody 5C5 (Sigma), a monoclonal antitropomyosin antibody, CH1 (Developmental Studies Hybridoma Bank), and a polyclonal anti-calsequestrin antibody, CSHe (SWant) was performed using pooled whole cardiac homogenates as previously described. 31,34 -36 After incubation with primary antibodies and washing, the membranes were incubated with the appropriate (antimouse or anti-rabbit IgG) 35 S-labeled secondary antibody (Amersham Inc) at a specific activity of 1 Ci/10 mL of blocking buffer.
The signal was quantitated using PhosphorImager and ImageQuant software.
Ca
2؉ Uptake Assay
Ca 2ϩ uptake measurements in whole mouse hearts were performed as described in recent studies. 31, 36, 37 
Quantitation of SERCA Phosphoenzyme Intermediate
The steady-state level of SERCA phosphoenzyme intermediate (E-P) was measured as described in a recent study. 38 Whole cardiac homogenate (0.2 mg/mL; prepared as mentioned above, except 50 mmol/L KP i was replaced by 20 mmol/L imidazole; pH 7.0) was added into 0.1 mL reaction mixture containing 20 mmol/L imidazole (pH 7.0), 100 mmol/L KCl, 5 mmol/L NaN 3 , and either 100 mol/L free Ca 2ϩ or 1 mmol/L EGTA. The reaction was started by the addition of 2 mol/L [␥-
32 P]ATP (specific activity, 10 Ci/nmol) at 0°C. The reaction was terminated after 30 s by the addition of 1 mL ice-cold stop solution (6% trichloroacetic acid, 0.3 mmol/L ATP, 5 mmol/L P i ). The samples were placed on ice for 5 minutes and then were vacuum filtered through the Millipore filter membranes. The filters were processed for scintillation counting. The SERCA E-P level was calculated as the difference between 32 P incorporation into protein in the presence and absence of added Ca 2ϩ .
Measurements of Ca 2؉ Transients and Contractile Parameters in Isolated Ventricular Myocytes
Ventricular cardiomyocytes were isolated as previously described. 31, 36, 39, 40 The isolated cells were washed and resuspended in a physiological buffer [132 mmol/L NaCl, 4.8 mmol/L KCl, 1.2 mmol/L MgCl 2 , 5 mmol/L glucose, 10 mmol/L HEPES (pH 7.2)] supplemented with 1.8 mmol/L Ca 2ϩ . Half of the cells from each heart then were used for mechanical studies, and the other half were used for measurements of intracellular free Ca 2ϩ transients. Intracellular free Ca 2ϩ transients were measured as described. 31, 36, 39, 40 Briefly, myocytes were loaded with 7.5 mol/L Fura-2 AM at 37°C for 15 minutes in the dark. After loading, cells were washed and resuspended in the physiological buffer. Cytosolic free calcium was measured by ratio imaging of 340 to 380 nm excitation fluorescence of Fura-2 AM (emission wavelength, 510 nm) using a photo scan dual spectrophotometer (Photon Thech, Inc) coupled with an Olympus IMT-2 UV fluorescent microscope with UV transparent optics.
Morphological and mechanical properties of myocytes were measured as described. 31, 36, 39, 40 Briefly, cells were placed in a well on the stage of an inverted microscope and were perfused continuously with oxygenated physiological buffer. Myocytes were field stimulated at 0.5 Hz, 5-ms pulse duration, for at least 40 s per pacing rate. Cell images were videotaped, and myocyte length, percentage of shortening, and peak rates of shortening (ϩdL/dt) and relengthening (ϪdL/dt) were quantitated by comparison with a calibrated micrometer on the microscope stage.
At least 5 cells were examined per mouse, and the values were averaged for mechanical parameters and Ca 2ϩ kinetics. Statistical analysis was based on the number of animals rather than the number of cells.
Measurements of Cardiac Contractile Parameters in Work-Performing Heart Preparations
The work-performing heart preparations were described in detail previously. [41] [42] [43] Age-matched TG and NTG mice (12 to 16 weeks old) were used. ECG and heart rates were recorded before opening of the chest and removal of the heart. The optimal venous return and the afterload required to maintain constant function of the hearts were 5 mL/min cardiac output and 50 mm Hg aortic pressure, respectively, providing a basal workload of 250 mLϫmm Hg/min. Heart rate, aortic pressure, left intraventricular pressure (IVP; systolic, diastolic, and end-diastolic), and atrial pressure were monitored continuously. The first derivative of IVP (ϩdP/dt and ϪdP/dt), the time to peak pressure (TPP)/mm Hg, and the time to half-relaxation (RT 1/2 )/ mm Hg were calculated with a custom-designed computer program. Venous return (equal to cardiac output) and aortic flows were measured continuously with a Dual Channel Transonic Flowmeter. Coronary flow was computer calculated as venous returnϪaortic flow.
Statistical Analysis
Statistical significance was determined by unpaired Student t test or ANOVA followed by the Newman-Keuls test as appropriate. If data were not distributed normally or failed equal variance tests after log 10 transformations, they were analyzed by nonparametric statistics (ie, Kruskal-Wallis for ANOVA designs or Mann-Whitney rank sum test for comparison between 2 groups of data). Values represent meanϮSEM of at least 3 determinations (nϭNo. of mice). A P value Ͻ0.05 was set as the criteria for statistical significance.
Results
Generation and Characterization of SERCA1a TG Mice
To direct cardiac-specific expression of the fast-twitch skeletal muscle, SR Ca 2ϩ -ATPase, the rat SERCA1a cDNA was linked to the mouse cardiac ␣-MHC promoter ( Figure 1A) . TG mice were generated, and 5 founder mice (Nos. 33, 38, 40, 48, and 50) were identified as carriers of the transgene by polymerase chain reaction analysis with specific primers. They were bred with FVB/N wild-type mice to establish germ-line transmission. All founder mice passed the transgene to their offspring. The SERCA1a TG mice cannot be distinguished phenotypically from NTG mice and reproduce well. The heart weight-to-body weight ratio was not different between TG and NTG animals. Histological examination of TG hearts (6 months old) did not reveal any evidence of cardiac pathology (data not shown).
Genomic Southern and dot blot analysis revealed that the SERCA1a transgene copy number ranged from 2 to 9 copies in different lines. Transgene expression was assessed by Northern blot analysis using total cardiac RNA from the F 1 heterozygotes and the rat SERCA1a cDNA 3Ј-noncoding region as a probe. The 3.5-kb SERCA1a mRNA was detected in TG lines 33, 38, 40, and 48. Line 38 carrying 9 copies of the transgene had the highest level of SERCA1a mRNA in the heart, whereas line 33 carrying 2 copies had the lowest SERCA1a mRNA level ( Figure 1B) . In this article, we report detailed characterization of the TG line 38 expressing the highest SERCA1a protein level. Heterozygous mice (12 to 16 weeks old) were used for biochemical, myocyte, and cardiac functional analysis.
Ectopic Expression of SERCA1a in TG Hearts Results in a 2.5-Fold Increase in the Total Amount of SERCA Protein
To detect the SERCA1a protein expression in TG hearts, Western blot analysis was performed using cardiac homogenates. SERCA1a antibody 33 detected a specific band only in TG hearts, but not in NTG hearts (see Figure 2A and 2B). Coomassie blue staining of SDS-PAGE separated proteins revealed that only SERCA band (110 kDa) was enhanced in TG cardiac microsomes compared with NTG microsomes (Figure 2A) . Western blot analysis with specific antibodies confirmed that this band indeed corresponded to SERCA (SERCA2a and SERCA1aϩSERCA2a in NTG and TG hearts, respectively; see Methods and Figure 2A ). Quantitative SDS-PAGE analysis showed that this band contain 2.5-fold more protein in TG microsomes compared with NTG microsomes (Figure 2A ). These data suggest that ectopic expression of SERCA1a in mouse hearts resulted in a 2.5-fold increase in the total SERCA protein level.
To determine whether SERCA1a overexpression altered the endogenous SERCA2a protein level in the heart, quantitative immunoblotting 34 was performed with cardiac homogenates using a SERCA2a-specific antibody. 32 The SERCA2a protein level was decreased by 50% in TG hearts compared with NTG hearts ( Figure 2B ). Inesi et al 25 also reported that SERCA1 overexpression in embryonic chick cardiac myocytes down-regulated (30% to 60%) the endogenous SERCA2a pump. In TG hearts, the total amount of SERCA (SERCA1aϩSERCA2a) was increased 2.5-fold (250%) compared with NTG hearts, whereas the level of SERCA2a protein was decreased to 50%. Therefore, the SERCA1a levelϭ(total SERCA)Ϫ(SERCA2a)ϭ250%Ϫ50%ϭ200%. Based on this, SERCA1a:SERCA2a ratio is 4:1 (200%:50%). This means that 80% of total SERCA pumps in TG hearts are represented by SERCA1a.
In addition, we addressed whether SERCA1a expression in the heart alters the expression levels of other proteins involved in calcium transport and contractile function. The quantitative immunoblotting using specific antibodies revealed no difference in the levels of actin, tropomyosin, calsequestrin, and phospholamban between TG and NTG hearts ( Figure 2B ). These data suggest that the ectopic expression of SERCA1a did not affect the expression level of other proteins in TG hearts.
The Steady-State Level of SERCA E-P and Maximal Velocity of SR Ca 2؉ Uptake Are Increased Significantly in SERCA1a TG Hearts
Ca 2ϩ translocation by SERCA pump is coupled tightly with the formation of E-P, 44 which under specific conditions could be trapped to quantitate the amount of active enzyme. 45 Therefore, we measured the steady-state level of E-P in TG and NTG cardiac homogenates. The steady-state level of E-P was 2.5-fold higher in TG hearts than in NTG hearts (154.33Ϯ4.47 and 60.57Ϯ3.96 pmol/mg, respectively; nϭ6; PϽ0.01), indicating that the level of active SERCA enzyme is 2.5-fold higher in TG hearts. These data are consistent with a 2.5-fold increase in the amount of total SERCA protein in TG hearts, demonstrating that the overexpressed SERCA1a pumps are functional.
To study the effects of SERCA1a overexpression on cardiac SR calcium transport function, the initial rates of ATP-dependent, oxalate-facilitated SR Ca 2ϩ uptake were measured. As shown in Figure 3 , Ca 2ϩ uptake rates were increased significantly in TG hearts compared with NTG hearts over the whole range of free Ca 2ϩ concentrations (0.03 to 3 mol/L). The maximal velocity of Ca 2ϩ uptake was 1.7-fold higher in TG hearts compared with NTG hearts (165.87Ϯ8.05 and 97.90Ϯ0.51 nmol/mg per minute, respectively; nϭ4; PϽ0.01; Figure 3 ). from TG and NTG mouse hearts was subjected to Northern blot analysis using rat SERCA1a cDNA 3Ј-noncoding region as a probe. Rat heart and rat fast-twitch skeletal muscle total RNA were used as controls. The transgene copy number in different mouse lines was determined by quantitative dot blot analysis using transgene-specific Hgh probe as described in Methods.
Cardiomyocytes Isolated from SERCA1a TG Hearts Demonstrate Faster Ca 2؉ Transients and Higher Contractility
To examine whether SERCA1a pump overexpression alters intracellular free Ca 2ϩ kinetics, left ventricular myocytes isolated from TG and NTG hearts were loaded with Fura-2 AM, and the phasic Ca 2ϩ signals during electrical pacing at 0.5 Hz (30 bpm) were examined (Figure 4) . The baseline cytosolic calcium signal was decreased by 38.1% in SERCA1a TG myocytes (Table 1) , suggesting a higher degree of Ca 2ϩ sequestration by SR. As a result, the amplitude of calcium signal was increased by 71.8% in TG myocytes. Although the 18% decrease in the absolute time for 80% decay of Ca 2ϩ signal (T 80 ) in TG myocytes was not statistically significant (Pϭ0.146), TG myocytes showed a 51.6% decrease (PϽ0.05) in T 80 normalized to the amplitude of calcium signal (T 80 nor), suggesting considerably faster Ca 2ϩ removal from the cytosol ( Table 1 ). The normalization was performed, because T 80 is a linear function of the calcium signal (which is increased) and the rate of decay of the signal (which is accelerated). 46 To determine how altered Ca 2ϩ kinetics affect contractility, mechanical properties of isolated cardiomyocytes were ex- Figure 2 . A, Quantitation of the total SERCA protein level in TG hearts. Increasing amounts of microsomal proteins from the TG and NTG hearts were separated by 6% SDS-PAGE. Top, Coomassie blue staining of representative gel. Arrows indicate the position of SERCA band in TG and NTG samples. Middle, After separation, the proteins were transferred onto nitrocellulose filters and stained transiently with Ponceau S, and the position of SERCA band was marked. After the stain was washed out, the filters were probed with SERCA2a and SERCA1a-specific antibodies. Ab indicates antibody. Bottom, Bar graph shows the total SERCA protein level in TG hearts. B, Western blot analysis of SERCA1a TG mouse hearts. Increasing amounts of TG and NTG cardiac proteins were separated in 10% SDS-PAGE, transferred onto nitrocellulose membrane, and probed with SERCA1a-, SERCA2a-, calsequestrin-, ␣-sarcomeric actin-, tropomyosin-, and phospholamban-specific antibodies. Pooled tissue homogenates from whole heart were used (6 hearts per group).
amined. Although TG and NTG myocytes showed no significant difference in the cell length and the extent of cell shortening, ϩdL/dt and ϪdL/dt were increased in TG myocytes by 50.0% and 66.6%, respectively (Table 1) .
SERCA1a TG Hearts Demonstrate Significantly Increased Contractility
To determine whether elevated Ca 2ϩ transport function in SERCA1a TG hearts would affect contractile performance, we implemented the isolated work-performing mouse heart preparations. [41] [42] [43] This allowed us to compare TG and NTG hearts at similar loading conditions without the influence of neural or hormonal input. At 50 mm Hg mean aortic pressure (afterload) and 5 mL/min venous return (an approximation of preload), TG hearts showed similar heart rates and left ventricular minute work (Table 2) . At the same time, the systolic pressure in TG hearts was increased by 17 mm Hg, and the diastolic pressure was decreased by 4 mm Hg, without a significant change in the end-diastolic pressure ( Table 2 ). The maximal rates of pressure development for contraction (ϩdP/dt) and relaxation (ϪdP/dt) were increased by 41.9% and 39.5%, respectively, and the TPP and the RT 1/2 decreased by 29.1% and 32.7%, respectively, in TG hearts ( Figure 5 ; Table 2 ).
Discussion
The data presented in this article clearly demonstrate that overexpression of the fast-twitch skeletal muscle SR Ca 2ϩ -ATPase in the mammalian heart results in significantly elevated Ca 2ϩ transport function and cardiac contractile performance. This is the first demonstration that SERCA1a can substitute functionally for SERCA2a in the intact heart. In addition, our studies suggest that the SERCA pump level is a critical determinant of myocardial contractility.
The work-performing heart preparations used in the present study enabled us to make definitive functional comparisons between TG mice and their wild-type NTG littermates. Although the SERCA1a TG mice and NTG mice had similar heart rates, body weights, and heart weight-to-body weight ratios, TG hearts revealed significantly altered cardiac contractile parameters: higher systolic and lower diastolic IVP, increased rates of pressure development for contraction (ϩdP/dt) and relaxation (ϪdP/dt), and shorter TPP and RT 1/2 . The cardiac myocyte data displayed in Figure 4 and Table  1 provide a mechanism for the enhanced rates of pressure development and decay that were observed in the isolated work-performing preparations of SERCA1a TG hearts. Analysis of Ca 2ϩ transients using Fura-2 AM indicated that the peak cytosolic calcium signal was not significantly different between TG and NTG myocytes. However, TG myocytes showed a considerably decreased basal cytosolic calcium signal. As a result, the amplitude of calcium signal was significantly augmented in TG myocytes. Normalized T 80 was reduced in TG myocytes, suggesting that the rate of calcium resequestration was enhanced. This acceleration of calcium cycling produced more rapid rates of myocyte shortening and relengthening in the absence of a significant increase in the extent of shortening. It is important to emphasize that Fura-2 AM ratio signal imaging provides a relative measure of the change in free cytosolic calcium over time. This and other fluorescent dye indicators permit a qualitative assessment of the rapid changes in calcium transients produced by EC coupling in heart cells, which is independent of changes in dye concentration and obviates the need for signal calibration. 31 In contrast, the use of calcium-sensitive microelectrodes permits accurate measurement of mean free cytosolic calcium concentration but does not permit a dynamic assessment of calcium cycling. Although it is possible to provide an estimate of absolute calcium concentration using fluorescent indicators, we and others have avoided this approach because of variable and unpredictable subcompartmentalization of calcium within the mitochondria.
In this study, we demonstrated that by ectopic expression of SERCA1a, we can achieve a 2.5-fold increase in the total amount of SERCA protein, with 80% represented by SERCA1a. The unaltered expression pattern of other proteins suggested that SR volume was not changed, but the SERCA pump density was increased. The corresponding 2.5-fold increase in the steady-state level of E-P revealed that the expressed SERCA1a pump is functional. Indeed, TG hearts demonstrated significantly higher rates of Ca 2ϩ uptake, suggesting that the SERCA1a pump can substitute functionally the endogenous SERCA2a isoform. Recent attempts to overexpress the SERCA2a cardiac isoform in the heart, however, resulted only in a modest increase in the total pump level. In our laboratory, ␣-MHC-driven SERCA2a overexpression resulted in a 4-fold increase in SERCA2a mRNA level but only in a 30% increase of total SERCA protein in mouse TG hearts. 42 In a separate study, He et al 47 reported a 20% increase in the total pump level, achieved using the human cytomegalovirus (enhancer)-chicken ␤-actin promoter. Similar results were reported for adenovirus-mediated gene transfer into cardiac myocytes. The adenoviral transfer of rat SERCA2a into rat ventricular neonatal myocytes resulted in a 1.1-fold increase, 24 whereas the transfer of rabbit SERCA2a resulted in a 1.5-fold increase in the total SERCA protein. 48 It should also be noted that the amount of SERCA protein is significantly lower in neonatal cardiac SR compared with adult cardiac SR. 37 Recently, Inesi et al, 25 using adenovirus-mediated gene transfer, showed that the SERCA1 pump can be overex- pressed in chick embryonic cardiac myocyte. SERCA1 overexpression down-regulated SERCA2a but resulted in a 4-fold increase in ATP-dependent calcium uptake. This study and our results suggest that the SERCA1 pump can be expressed at a much higher level in cardiac myocytes. The higher level of SERCA1a expression in TG hearts may be due to unique properties of the SERCA1a pump, including more efficient integration into the SR membrane. In addition, a 50% reduction in the endogenous SERCA2a level in TG hearts suggests that SERCA1a competes more efficiently for pump integration sites. Ectopic expression in the heart of some other muscle proteins, including ␤-tropomyosin 43 and fasttwitch skeletal muscle myosin light chain isoform MLC2, 49 also resulted in functional replacement of the endogenous isoforms, depending on the protein expression level. However, the mechanism(s) regulating the SERCA pump synthesis, integration, and turnover (half-life) in the SR membrane is/are not understood presently and need(s) further investigation.
In conclusion, we have shown that the fast-twitch skeletal muscle SERCA1a pump can functionally substitute the endogenous SERCA2a isoform in the heart without producing any cardiac pathology. Furthermore, we have shown that the amount of SERCA protein in the heart can be increased up to 2.5-fold by overexpression, suggesting that the cardiac SR can accommodate more SERCA protein. Most importantly, we have shown that SERCA1a overexpression leads to significantly elevated contractile performance, demonstrating that the SR Ca 2ϩ -ATPase level is a critical factor in determining cardiac contractility. Our studies pave the way for the potential use of the SERCA1a pump for gene therapy to enhance myocardial performance in failing hearts. In addition, the SERCA1a TG model is an excellent system to use when studying how changes in the level of SR Ca 2ϩ -ATPase can influence overall intracellular Ca 2ϩ homeostasis and cardiac muscle contractility. Figure 5 . Cardiac performance in isolated TG hearts. TG and NTG hearts were studied using isolated work-performing heart preparations under equal basal preloads, afterloads, and similar heart rates. The rates of contraction and relaxation are significantly increased in SERCA1a TG hearts. The values for maximal rates of pressure development for (A) contraction (ϩdP/dt), (B) relaxation (ϪdP/dt), (C) TPP, and (D) RT 1/2 are shown as meanϮSEM. ***PϽ0.001.
